ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival

Annals of Hematology

Volumn 75, Issue 1-2, 1997, Pages 41-46

  Dugan, M J ^c   DeFor, T E ^b   Steinbuch, M ^b   Filipovich, A H ^d   Weisdorf, D J ^a,b  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Indiana Blood and Marrow Transplant ^*  (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anti thymocyte globulin (ATG); Graft versus host disease; Therapy

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HORSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTOXINS; LIFE TABLES; MALE; METHOTREXATE; PREDNISONE; RETROSPECTIVE STUDIES; RICIN; SALVAGE THERAPY; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 0030851117     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050310     Document Type: Article

References (14)

1. Byers VS, Henslee PJ, Kernan NA, Blazar BR, Gingrich R, Phillips GL, LeMaistre CF, Gilliland G, Antin JH, Martin P, Tutscha PJ, Trown P, Ackerman SK, O'Reilly RJ, Scannon PJ (1990) Use of an anti-pan-T-lymphocyte ricin A chain immunotoxin in steroid-resistant acute graft-versus-host disease. Blood 75:1426-1432
2. Doney KC, Weiden PL, Storb R, Thomas ED (1981) Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1-8
3. Gratama JW, Jansen J, Lipovich RA, Tanke HJ, Goldstein G, Zwaan FE (1984) Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Transplantation 38:469-474
4. Heslop HE, Benaim E, Brenner MK, Krance RA, Stricklin LM, Rochester RJ, Billing R (1995) Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1. Lancet 346:805-806
5. Hings IM, Severson R, Filipovich AH, Blazar BR, Kersey JH, Ramsay NKC, McGlave PB, Weisdorf DJ (1994) Treatment of moderate and severe aGVHD after allogeneic bone marrow transplantation. Transplantation 58:437-442
6. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB (1990) A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 76:1464-1472
7. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, Hansen JA (1991) A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 77:1821-1828
8. Martin PJ, Nelson BJ, Appelbaum FR, Anasetti C, Deeg HJ, Hansen JA, McDonald GB, Nash RA, Sullivan KM, Witherspoon RP, Scannon PJ, Friedmann N, Storb R (1996) Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic bone marrow transplantation. Blood 88:824-830
9. Racadot E, Milpied N, Bordigoni P, Cahn JY, Plouvier E, Lioure B, Lutz P, Wildenes J, Herve P (1994) Sequential use of 3 monoclonal antibodies (MABs) in corticoresistant acute GVH. A multicentric pilot study in 15 patients. Blood 84 [Suppl 1]:207a
10. Roy J, McGlave PB, Filipovich AH, Miller WJ, Blazar BR, Ramsay NKC, Kersey JH, Weisdorf DJ (1992) Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant 10:77-82
11. Storb R, Kolb HJ, Graham TC, Kolb H, Weiden PL, Thomas ED (1973) Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. Blood 42:601-609
12. Storb R, Gluckman E, Thomas ED, Buckner CD, Clift RA, Fefer A, Glucksberg H, Graham TC, Johnson FL, Lerner KG, Neiman PE, Ochs H (1974) Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood 44:57-75
13. Weisdorf DJ, Haake R, Blazar B, Miller WJ, McGlave PB, Ramsay NKC, Kersey J, Filipovich A (1990) Treatment of moderate/severe graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 75:1024-1030
14. Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B, Ramsay NKC, Kersey J, Filipovich A (1990) Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 76:624-629